Cargando…
Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
BACKGROUND: Globally the incidence of cancer is about 19.3 million new cases per year. Chemotherapy is among the standard treatments for cancer but neutropenia and febrile neutropenia are the most common side effects. OBJECTIVE: To assess the incidences of chemotherapy-induced neutropenia, febrile-n...
Autores principales: | Dessalegn, Mekonnen, Fantahun, Mengistu, Yesufe, Abdu Adem, Hussein, Mintewab, Tsegaye, Aster |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968436/ https://www.ncbi.nlm.nih.gov/pubmed/36855574 http://dx.doi.org/10.2147/CMAR.S386181 |
Ejemplares similares
-
Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020) -
Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital
por: Mohammed, Husnia Bedewi, et al.
Publicado: (2019) -
Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)